Abstract
Acute heart failure (AHF) is a severe complication after cardiac surgery with cardiopulmonary bypass (CPB). Although some AHF biomarkers have been used in clinic, they have limitations when applied in the prediction and diagnosis of AHF after cardiac surgery with CPB, and there are still no effective and specific biomarkers. We and other researchers have shown that circulating microparticles (MPs) increased in a variety of cardiovascular diseases. However, whether the concentration of circulating MPs could be a new biomarker for AHF after cardiac surgery remains unknown. Here, 90 patients undergoing cardiac surgery with CPB and 45 healthy subjects were enrolled. Patients were assigned into AHF (n=14) or non-AHF (n=76) group according to the diagnosis criteria of AHF. The concentrations of circulating MPs were determined before, as well as 12 h and 3 days after operation with nanoparticle tracking analysis technique. MPs concentrations in patients before surgery were significantly higher than those of healthy subjects. Plasma levels of MPs were significantly elevated at 12 h after surgery in patients with AHF, but not in those without AHF, and the circulating MPs concentrations at 12 h after surgery were higher in AHF group compared with non-AHF group. Logistic regression analysis indicated that MPs concentration at postoperative 12 h was an independent risk factor for AHF. The area under receiver operating characteristic curve for MPs concentration at postoperative 12 h was 0.81 and the best cut-off value is 5.20×108 particles mL−1 with a sensitivity of 93% and a specificity of 10%. These data suggested that the concentration of circulating MPs might be a new biomarker for the occurrence of AHF after cardiac surgery with CPB.
Similar content being viewed by others
References
Bank, I.E.M., Timmers, L., Gijsberts, C.M., Zhang, Y.N., Mosterd, A., Wang, J.W., Chan, M.Y., De Hoog, V., Lim, S.K., Sze, S.K., et al. (2015). The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease. Expert Rev Mol Diagn 15, 15771588.
Berezin, A.E. (2016). Prognostication in different heart failure phenotypes: The role of circulating biomarkers. J Circ Biomark 5, 6.
Berezin, A.E. (2017). Microparticles in chronic heart failure. Adv Clin Chem 81, 1–41.
Berezin, A.E., Kremzer, A.A., Berezina, T.A., and Martovitskaya, Y.V. (2015a). Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation. BBA Clin 4, 69–75.
Berezin, A.E., Kremzer, A.A., Martovitskaya, Y.V., Samura, T.A., and Berezina, T.A. (2015b). The association of subclinical hypothyroidism and pattern of circulating endothelial-derived microparticles among chronic heart failure patients. Res Cardiovasc Med 4, 7.
Berezin, A.E., Kremzer, A.A., Samura, T.A., Berezina, T.A., and Kruzliak, P. (2015c). Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. J Endocrinol Invest 38, 865–874.
Brouwers, F.P., de Boer, R.A., van der Harst, P., Voors, A.A., Gansevoort, R.T., Bakker, S.J., Hillege, H.L., van Veldhuisen, D.J., and van Gilst, W. H. (2013). Incidence and epidemiology of new onset heart failure with preserved v. reduced ejection fraction in a community-based cohort: 11-year follow-up of prevend. Eur Heart J 34, 1424–1431.
Burger, D., and Touyz, R.M. (2012). Cellular biomarkers of endothelial health: Microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 6, 85–99.
Burger, D., Schock, S., Thompson, C.S., Montezano, A.C., Hakim, A.M., and Touyz, R.M. (2013). Microparticles: Biomarkers and beyond. Clin Sci 124, 423–441.
Chow, S.L., Maisel, A.S., Anand, I., Bozkurt, B., de Boer, R.A., Felker, G. M., Fonarow, G.C., Greenberg, B., Januzzi Jr, J.L., Kiernan, M.S., et al. (2017). Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the american heart association. Circulation 135, e1054.
Ci, H.B., Ou, Z.J., Chang, F.J., Liu, D.H., He, G.W., Xu, Z., Yuan, H.Y., Wang, Z.P., Zhang, X., and Ou, J.S. (2013). Endothelial microparticles increase in mitral valve disease and impair mitral valve endothelial function. Am J Physiol Endocrinol Metab 304, E695–E702.
Coumans, F.A.W., Brisson, A.R., Buzas, E.I., Dignat-George, F., Drees, E.E.E., El-Andaloussi, S., Emanueli, C., Gasecka, A., Hendrix, A., Hill, A.F., et al. (2017). Methodological guidelines to study extracellular vesicles. Circ Res 120, 1632–1648.
Das, S., and Halushka, M.K. (2015). Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 24, 199–206.
Delcayre, C., and Swynghedauw, B. (2002). Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Mol Cell Cardiol 34, 1577–1584.
Densmore, J.C., Signorino, P.R., Ou, J., Hatoum, O.A., Rowe, J.J., Shi, Y., Kaul, S., Jones, D.W., Sabina, R.E., Pritchard Jr, K.A., et al. (2006). Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock 26, 464–471.
Dignat-George, F., and Boulanger, C.M. (2011). The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 31, 27–33.
Dragovic, R.A., Gardiner, C., Brooks, A.S., Tannetta, D.S., Ferguson, D.J. P., Hole, P., Carr, B., Redman, C.W.G., Harris, A.L., Dobson, P.J., et al. (2011). Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 7, 780–788.
Feng, Y.L., and Yu, X.Y. (2011). Cardinal roles of miRNA in cardiac development and disease. Sci China Life Sci 54, 1113–1120.
Fu, L., Hu, X.X., Lin, Z.B., Chang, F.J., Ou, Z.J., Wang, Z.P., and Ou, J.S. (2015). Circulating microparticles from patients with valvular heart disease and cardiac surgery inhibit endothelium-dependent vasodilation. J Thorac Cardiovasc Surg 150, 666–672.
Gong, J., Jaiswal, R., Dalla, P., Luk, F., and Bebawy, M. (2015). Microparticles in cancer: A review of recent developments and the potential for clinical application. Semin Cell Dev Biol 40, 35–40.
Greening, D.W., Gopal, S.K., Mathias, R.A., Liu, L., Sheng, J., Zhu, H.J., and Simpson, R.J. (2015). Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression. Semin Cell Dev Biol 40, 60–71.
Heart Failure Group of Chinese Society of Cardiology of Chinese Medical, A. Chinese Heart Failure Association of Chinese Medical Doctor, A., and Editorial Board of Chinese Journal Of, C. (2018). Chinese guidelines for the diagnosis and treatment of heart failure 2018. Chin J Cardiovasc Dis 46, 760–789.
Jian, Y.P., Yuan, H.X., Hu, K.H., Chen, C., Li, Y.Q., Li, Y., Yang, T.X., Ou, Z.J., and Ou, J.S. (2019). Protein compositions changes of circulating microparticles in patients with valvular heart disease subjected to cardiac surgery contribute to systemic inflammatory response and disorder of coagulation. Shock 52, 487–496.
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J.P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., and Théry, C. (2016). Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA 113, E968–E977.
Levy, D., Kenchaiah, S., Larson, M.G., Benjamin, E.J., Kupka, M.J., Ho, K.K.L., Murabito, J.M., and Vasan, R.S. (2002). Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347, 13971402.
Lin, Z.B., Ci, H.B., Li, Y., Cheng, T.P., Liu, D.H., Wang, Y.S., Xu, J., Yuan, H.X., Li, H.M., Chen, J., et al. (2017). Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction. J Transl Med 15, 4.
Liu, Y., He, Z., Zhang, Y., Dong, Z., Bi, Y., Kou, J., Zhou, J., and Shi, J. (2016). Dissimilarity of increased phosphatidylserine-positive microparticles and associated coagulation activation in acute coronary syndromes. Coron Artery Dis 27, 365–375.
Mahmoud, A.M., Wilkinson, F.L., McCarthy, E.M., Moreno-Martinez, D. M., Langford-Smith, A., Romero, M., Duarte, J., and Alexander, M.Y. (2017). Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. FASEB J 31, 4636–4648.
Martinez, M.C., and Andriantsitohaina, R. (2011). Microparticles in angiogenesis. Circ Res 109, 110–119.
Nichols, M., Townsend, N., Scarborough, P., and Rayner, M. (2014). Cardiovascular disease in europe 2014: Epidemiological update. Eur Heart J 35, 2950–2959.
Ou, Z.J., Chang, F.J., Luo, D., Liao, X.L., Wang, Z.P., Zhang, X., Xu, Y.Q., and Ou, J.S. (2011). Endothelium-derived microparticles inhibit angiogenesis in the heart and enhance the inhibitory effects of hypercholesterolemia on angiogenesis. Am J Physiol Endocrinol Metab 300, E661–E668.
Peng, L.N., Li, Y.J., Zhang, L., and Yu, W.Q. (2013). Moving RNA moves RNA forward. Sci China Life Sci 56, 914–920.
Peterson, D.B., Sander, T., Kaul, S., Wakim, B.T., Halligan, B., Twigger, S., Pritchard Jr., K.A., Oldham, K.T., and Ou, J.S. (2008). Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 8, 2430–2446.
Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G.F., Coats, A.J.S., Falk, V., González-Juanatey, J.R., Harjola, V.P., Jankowska, E.A., et al. (2016). 2016 esc guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 18, 891–975.
Rohde, L.E., Bertoldi, E.G., Goldraich, L., and Polanczyk, C.A. (2013). Cost-effectiveness of heart failure therapies. Nat Rev Cardiol 10, 338354.
Saari, H., Lázaro-Ibáñez, E., Viitala, T., Vuorimaa-Laukkanen, E., Siljander, P., and Yliperttula, M. (2015). Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J Control Release 220, 727–737.
Sander, T.L., Ou, J.S., Densmore, J.C., Kaul, S., Matus, I., Twigger, S., Halligan, B., Greene, A.S., Pritchard, K.A., and Oldham, K.T. (2008). Protein composition of plasminogen activator inhibitor type 1-derived endothelial microparticles. Shock 29, 504–511.
Souza, A.C.P., Yuen, P.S.T., and Star, R.A. (2015). Microparticles: Markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int 87, 1100–1108.
Ural, D., Çavuşoğlu, Y., Eren, M., Karaüzüm, K., Temizhan, A., Yilmaz, M.B., Zoghi, M., Ramassubu, K., and Bozkurt, B. (2015). Diagnosis and management of acute heart failure. Anatol J Cardiol 15, 860889.
Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey Jr., D.E., Drazner, M.H., Fonarow, G.C., Geraci, S.A., Horwich, T., Januzzi, J.L., et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol 62, e147–e239.
Zhang, X., Liu, H., Gao, J., Zhu, M., Wang, Y., Jiang, C., and Xu, M. (2019). Metabolic disorder in the progression ofheart failure. Sci China Life Sci 62, 1153–1167.
Zhou, K., and Hong, T. (2017). Cardiac BIN1 (cBIN1) is a regulator of cardiac contractile function and an emerging biomarker of heart muscle health. Sci China Life Sci 60, 257–263.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81670392, 81600382, 81770241, 81830013, 81970363), the National Science Fund for Distinguished Young Scholars (81325001), the International Cooperation Project (2015DFA31070) from the Ministry of Science and Technology of China, the National Key Research and Development Program of China (2016YFC0903000), the Changjiang Scholars Program from the Ministry of Education of China, Guangdong Natural Science Fund Committee (2015A030312009), the Guangdong Pearl River Scholars Program, and the Sun Yat-sen University Clinical Research 5010 Program (2014002). The five and five projects are from The First Affiliated Hospital, Sun Yat-sen University. The authors would like to thank the patients as well as staffs at the First Affiliated Hospital, Sun Yat-sen University for their assistance throughout this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance and ethics The author(s) declare that they have no conflict of interest. The Ethics Review Board of the First Affiliated Hospital, Sun Yat-sen University approved this study with the written informed consents of all participants obtained. This study also complied with the Declaration of Helsinki.
Supporting information
11427_2020_1708_MOESM1_ESM.pdf
Concentration of circulating microparticles: a new biomarker of acute heart failure after cardiac surgery with cardiopulmonary bypass
Rights and permissions
About this article
Cite this article
Li, Y., Yuan, H., Chen, C. et al. Concentration of circulating microparticles: a new biomarker of acute heart failure after cardiac surgery with cardiopulmonary bypass. Sci. China Life Sci. 64, 107–116 (2021). https://doi.org/10.1007/s11427-020-1708-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-020-1708-9